<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Prestige Brand Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc</link>
<description>Latest news and press releases for Prestige Brand Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 20 Mar 2026 10:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/prestige-brand-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a91678dffbe2df10ca06.webp</url>
<title>Prestige Brand Holdings Inc</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc</link>
</image>
<item>
<title>Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-announces-agreement-to-acquire-breathe-rightr-the-leader-in-nasal-strips</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-announces-agreement-to-acquire-breathe-rightr-the-leader-in-nasal-strips</guid>
<pubDate>Fri, 20 Mar 2026 10:15:00 GMT</pubDate>
<description>Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 millionBreathe Right is an iconic and category‑leading brand with strong margins and cash flow generationAcquisition reinforces Prestige’s long-term organic growth algorithmTransaction expected to close in Prestige’s first half fiscal 2027 TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entere</description>
</item>
<item>
<title>PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD FOURTH QUARTER SALES, ADJUSTED EBITDA, AND ADJUSTED EPS, ANNOUNCES THE SALE OF ITS INTEREST IN SHAW BAKERS, DECLARES FIRST QUARTER DIVIDEND AND APPOINTS NEW DIRECTOR TO ITS BOARD</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/premium-brands-holdings-corporation-reports-record-fourth-quarter-sales-adjusted-ebitda-and-adjusted-eps-announces-the-sale-of-its-interest-in-shaw-bakers-declares-first-quarter-dividend-and-appoints-new-director-to-its-board-1</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/premium-brands-holdings-corporation-reports-record-fourth-quarter-sales-adjusted-ebitda-and-adjusted-eps-announces-the-sale-of-its-interest-in-shaw-bakers-declares-first-quarter-dividend-and-appoints-new-director-to-its-board-1</guid>
<pubDate>Thu, 19 Mar 2026 10:30:00 GMT</pubDate>
<description>Premium Brands Holdings Corporation (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, announced today its results for the fourth quarter of 2025</description>
</item>
<item>
<title>Prestige Consumer Healthcare Selects Horizon Media as Agency of Record to Drive Market Growth</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-selects-horizon-media-as-agency-of-record-to-drive-market-growth</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-selects-horizon-media-as-agency-of-record-to-drive-market-growth</guid>
<pubDate>Mon, 16 Mar 2026 11:00:00 GMT</pubDate>
<description>Prestige Consumer Healthcare, a leader in over-the-counter healthcare and wellness products, has named Horizon Media its media planning and buying agency following a competitive four-month review. The partnership is designed to expand Prestige's market leadership by combining Horizon's brand strategy expertise and data-powered audience intelligence to drive relevance and measurable business growth.</description>
</item>
<item>
<title>Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-110000039</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-110000039</guid>
<pubDate>Thu, 05 Feb 2026 11:00:00 GMT</pubDate>
<description>Revenue of $283.4 million in Q3, ahead of outlookDiluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22Repurchased approximately 0.8 million shares opportunistically in Q3Successfully closed acquisition of eye care supplier Pillar5 Pharma, Inc. in December, as expectedNarrowing Outlook Range of Fiscal 2026 Revenue and Adjusted Diluted EPS TARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported</description>
</item>
<item>
<title>Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-announces-fiscal-130000047</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-announces-fiscal-130000047</guid>
<pubDate>Mon, 12 Jan 2026 13:00:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestig</description>
</item>
<item>
<title>Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-110000708</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-110000708</guid>
<pubDate>Thu, 06 Nov 2025 11:00:00 GMT</pubDate>
<description>Revenue of $274.1 million in Q2, ahead of outlookDiluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09Repurchased approximately 1.1 million shares opportunistically in Q2Fiscal 2026 revenue outlook unchanged; Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous range TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and fi</description>
</item>
<item>
<title>Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-210000163</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-210000163</guid>
<pubDate>Mon, 06 Oct 2025 21:00:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerh</description>
</item>
<item>
<title>Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-present-barclays-110000410</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-present-barclays-110000410</guid>
<pubDate>Thu, 04 Sep 2025 11:00:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the “Investors” section and the “Events and Presentations” tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those</description>
</item>
<item>
<title>Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-100000813</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-100000813</guid>
<pubDate>Thu, 07 Aug 2025 10:00:00 GMT</pubDate>
<description>Revenue of $249.5 million in Q1; decline driven by limited eye care supplyDiluted EPS of $0.95 in Q1, up approximately 6% versus prior year Adjusted Diluted EPS of $0.90Announces agreement to acquire current eye care supplier Pillar5 PharmaRevising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fi</description>
</item>
<item>
<title>TheraTears® Unveils "It's a Science" Marketing Campaign</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/theratears-unveils-science-marketing-campaign-121500962</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/theratears-unveils-science-marketing-campaign-121500962</guid>
<pubDate>Tue, 05 Aug 2025 12:15:00 GMT</pubDate>
<description>TheraTears®, a leading brand in dry eye relief under Prestige Consumer Healthcare, is thrilled to announce the launch of its innovative "It's a Science" marketing campaign. This campaign highlights the science-backed formulation of TheraTears® eye drops, emphasizing their unique blend of the five vital electrolytes found in natural tears and the formula's immediate and long-lasting hydration.</description>
</item>
<item>
<title>Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-120000984</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-120000984</guid>
<pubDate>Tue, 15 Jul 2025 12:00:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To</description>
</item>
<item>
<title>Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/medtech-products-inc-issues-nationwide-recall-of-little-remediesr-honey-cough-syrup-due-to-microbial-contamination</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/medtech-products-inc-issues-nationwide-recall-of-little-remediesr-honey-cough-syrup-due-to-microbial-contamination</guid>
<pubDate>Tue, 17 Jun 2025 21:38:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contami</description>
</item>
<item>
<title>Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-present-203000160</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-present-203000160</guid>
<pubDate>Mon, 09 Jun 2025 20:30:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., June 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference virtually on Wednesday, June 11, 2025 at 10:30 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.co</description>
</item>
<item>
<title>UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/updated-prestige-consumer-healthcare-inc-110900980</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/updated-prestige-consumer-healthcare-inc-110900980</guid>
<pubDate>Thu, 08 May 2025 11:09:00 GMT</pubDate>
<description>Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- P</description>
</item>
<item>
<title>Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-100000475</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-inc-reports-100000475</guid>
<pubDate>Thu, 08 May 2025 10:00:00 GMT</pubDate>
<description>Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- P</description>
</item>
<item>
<title>Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results</title>
<link>https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-210000357</link>
<guid isPermaLink="true">https://6ix.com/company/prestige-brand-holdings-inc/news/prestige-consumer-healthcare-release-fiscal-210000357</guid>
<pubDate>Thu, 10 Apr 2025 21:00:00 GMT</pubDate>
<description>TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthc</description>
</item>
</channel>
</rss>